AI assistant
Sending…
RESMED INC — Director's Dealing 2025
Nov 4, 2025
30071_dirs_2025-11-04_e55a6153-7365-4184-bc96-a9d96c77957e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2025-11-03
Reporting Person: Sandercock Brett (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-03 | ResMed Common Stock | M | 2000 | $101.64 | Acquired | 88745 | Direct |
| 2025-11-03 | ResMed Common Stock | S | 3000 | $247.54 | Disposed | 85745 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-03 | ResMed Common Stock Options | $101.64 | M | 2000 | Disposed | 2025-11-14 | ResMed Common Stock (2000) | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
F2: Represents date options first become exercisable. Options vest 1/3 per year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29